BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8195029)

  • 1. Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicity.
    Naylor MA; Sutton BM; Nolan J; O'Neill P; Fielden EM; Adams GE; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):333-7. PubMed ID: 8195029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, metabolism and distribution of 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-A] pyrido [3,2-E] pyrazine-5-oxide in C3H mice.
    Sutton BM; Reeves NJ; Naylor MA; Fielden EM; Cole S; Adams GE; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):339-44. PubMed ID: 8195030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymology of the reduction of the novel fused pyrazine mono-n-oxide bioreductive drug, RB90740 roles for P450 reductase and cytochrome b5 reductase.
    Barham HM; Stratford IJ
    Biochem Pharmacol; 1996 Mar; 51(6):829-37. PubMed ID: 8602879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines.
    Naylor MA; Stephens MA; Nolan J; Sutton B; Tocher JH; Fielden EM; Adams GE; Stratford IJ
    Anticancer Drug Des; 1993 Dec; 8(6):439-61. PubMed ID: 8286012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugs.
    Wardman P; Priyadarsini KI; Dennis MF; Everett SA; Naylor MA; Patel KB; Stratford IJ; Stratford MR; Tracy M
    Br J Cancer Suppl; 1996 Jul; 27():S70-4. PubMed ID: 8763850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubation.
    Brodfüehrer JI; Moore DJ; Melder DC; Wilke TJ; Powis G
    Invest New Drugs; 1988 Apr; 6(1):3-9. PubMed ID: 3410664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fused pyrazine mono-n-oxides as bioreductive drugs. II Cytotoxicity in human cells and oncogenicity in a rodent transformation assay.
    Langmuir VK; Laderoute KR; Mendonca HL; Sutherland RM; Hei TK; Liu SX; Hall EJ; Naylor MA; Adams GE
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):79-84. PubMed ID: 12118568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitro.
    Naylor MA; Swann E; Everett SA; Jaffar M; Nolan J; Robertson N; Lockyer SD; Patel KB; Dennis MF; Stratford MR; Wardman P; Adams GE; Moody CJ; Stratford IJ
    J Med Chem; 1998 Jul; 41(15):2720-31. PubMed ID: 9667963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; van Zijl P; Denny WA; Wilson WR
    J Med Chem; 1995 Mar; 38(7):1229-41. PubMed ID: 7707325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo.
    Naylor MA; Adams GE; Haigh A; Cole S; Jenner T; Robertson N; Siemann D; Stephens MA; Stratford IJ
    Anticancer Drugs; 1995 Apr; 6(2):259-69. PubMed ID: 7795274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel N-oxides as bioreductive drugs.
    Naylor MA
    Oncol Res; 1994; 6(10-11):483-91. PubMed ID: 7620216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin.
    Walton MI; Workman P
    Biochem Pharmacol; 1990 Jun; 39(11):1735-42. PubMed ID: 2344370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
    J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
    Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
    J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrobenzyl mustard quaternary salts: a new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreduction.
    Denny WA; Wilson WR; Tercel M; Van Zijl P; Pullen SM
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):317-21. PubMed ID: 8195026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and radiolytic reduction of 4-alkylamino-5-nitroquinoline bioreductive drugs. Relationship to hypoxia-selective cytotoxicity.
    Siim BG; Atwell GJ; Wilson WR
    Biochem Pharmacol; 1994 Oct; 48(8):1593-604. PubMed ID: 7980625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioreductive metabolism of SR-4233 (WIN 59075) by whole cell suspensions under aerobic and hypoxic conditions: role of the pentose cycle and implications for the mechanism of cytotoxicity observed in air.
    Tuttle SW; Hazard L; Koch CJ; Mitchell JB; Coleman CN; Biaglow JE
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):357-62. PubMed ID: 8195033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
    J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaching zero discharge in uranium reprocessing: photochemical reduction of uranyl.
    Mccleskey TM; Foreman TM; Hallman EE; Burns CJ; Sauer NN
    Environ Sci Technol; 2001 Feb; 35(3):547-51. PubMed ID: 11351727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.